MX9100454A - Nuevos peptidos inmunosupresores y metodo para su preparacion - Google Patents
Nuevos peptidos inmunosupresores y metodo para su preparacionInfo
- Publication number
- MX9100454A MX9100454A MX9100454A MX9100454A MX9100454A MX 9100454 A MX9100454 A MX 9100454A MX 9100454 A MX9100454 A MX 9100454A MX 9100454 A MX9100454 A MX 9100454A MX 9100454 A MX9100454 A MX 9100454A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- new immunosuppressive
- immunosuppressive peptides
- peptides
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56061590A | 1990-08-01 | 1990-08-01 | |
US65448291A | 1991-02-12 | 1991-02-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9100454A true MX9100454A (es) | 1992-04-01 |
Family
ID=27072401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9100454A MX9100454A (es) | 1990-08-01 | 1991-07-31 | Nuevos peptidos inmunosupresores y metodo para su preparacion |
Country Status (6)
Country | Link |
---|---|
AU (1) | AU8305491A (es) |
IE (1) | IE912701A1 (es) |
IL (1) | IL99008A0 (es) |
MX (1) | MX9100454A (es) |
PT (1) | PT98501A (es) |
WO (1) | WO1992002543A1 (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993005011A1 (en) * | 1991-08-29 | 1993-03-18 | Sandoz Ltd. | Novel immunosuppressants |
US7252829B1 (en) | 1998-06-17 | 2007-08-07 | Idm Pharma, Inc. | HLA binding peptides and their uses |
US7611713B2 (en) | 1993-03-05 | 2009-11-03 | Pharmexa Inc. | Inducing cellular immune responses to hepatitis B virus using peptide compositions |
US9340577B2 (en) | 1992-08-07 | 2016-05-17 | Epimmune Inc. | HLA binding motifs and peptides and their uses |
AU668772B2 (en) | 1992-08-31 | 1996-05-16 | Ludwig Institute For Cancer Research | Isolated nonapeptide derived from mage-3 gene and presented by HLA-A1, and uses thereof |
US6222012B1 (en) | 1992-08-31 | 2001-04-24 | Ludwig Institute For Cancer Research | Isolated nonapeptides presented by HLA molecules, and uses thereof |
US5405940A (en) * | 1992-08-31 | 1995-04-11 | Ludwig Institute For Cancer Research | Isolated nonapeptides derived from MAGE genes and uses thereof |
US5589458A (en) * | 1992-11-13 | 1996-12-31 | Thomas Jefferson University | Compounds that inhibit T cell proliferation and methods for using the same |
US5385918A (en) * | 1993-02-09 | 1995-01-31 | Miles Inc. | Aminomethylene-peptides as immunosuppressants |
US6413935B1 (en) | 1993-09-14 | 2002-07-02 | Epimmune Inc. | Induction of immune response against desired determinants |
DE69435171D1 (de) | 1993-09-14 | 2009-01-08 | Pharmexa Inc | Pan dr-bindeproteinen zur erhöhung der immunantwort |
US6509165B1 (en) | 1994-07-08 | 2003-01-21 | Trustees Of Dartmouth College | Detection methods for type I diabetes |
AU6099496A (en) * | 1995-06-07 | 1996-12-30 | G.D. Searle & Co. | Pipecolic acid derivatives of proline threonine amides usefu l for the treatment of rheumatoid arthritis |
AU1749597A (en) * | 1996-01-19 | 1997-08-11 | Virginia Mason Research Center | Allele-specific peptide epitope strategy for vaccine development |
GB9702377D0 (en) * | 1996-02-23 | 1997-03-26 | Zeneca Ltd | Peptide derivatives |
TR199802537T2 (xx) | 1996-06-07 | 1999-03-22 | Zeneca Limited | Peptit t�revleri. |
GB9621836D0 (en) * | 1996-10-19 | 1996-12-11 | Zeneca Ltd | Peptide compounds |
GB9624562D0 (en) | 1996-11-27 | 1997-01-15 | Zeneca Ltd | Peptide derivatives |
US6413517B1 (en) | 1997-01-23 | 2002-07-02 | Epimmune, Inc. | Identification of broadly reactive DR restricted epitopes |
FR2763071B1 (fr) * | 1997-05-07 | 2003-05-16 | Centre Nat Rech Scient | Analogues peptidiques, et leurs utilisations notamment dans des compositions pharmaceutiques et pour le diagnostic |
IL141021A0 (en) | 1998-07-23 | 2002-02-10 | Yeda Res & Dev | Treatment of autoimmune conditions with copolymer 1 and related copolymers |
ES2527760T3 (es) | 1998-07-23 | 2015-01-29 | Yeda Research And Development Co., Ltd. | Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos |
CA2336238A1 (en) * | 1998-07-23 | 2000-02-03 | The President And Fellows Of Harvard College | Synthetic peptides and methods of use for autoimmune disease therapies |
US6800287B2 (en) | 1998-09-25 | 2004-10-05 | Yeda Research And Development Co., Ltd. | Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
EP1128839A4 (en) * | 1998-11-12 | 2002-10-09 | Yeda Res & Dev | PHARMACEUTICAL COMPOSITIONS CONTAINING COPOLYMERS OF SYNTHETIC PEPTIDES AND METHODS FOR PREVENTING AND TREATING GVHD AND HVGD |
US7053043B1 (en) | 1999-07-23 | 2006-05-30 | Yeda Research And Development Co.Ltd. | Pharmaceutical compositions comprising synthetic peptide copolymers and methods for preventing and treating GVHD and HVGD |
JP4776131B2 (ja) | 1999-11-18 | 2011-09-21 | エピミューン インコーポレイテッド | ヘテロクリティックアナログおよび関連方法 |
US7026443B1 (en) | 1999-12-10 | 2006-04-11 | Epimmune Inc. | Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions |
US7462354B2 (en) | 1999-12-28 | 2008-12-09 | Pharmexa Inc. | Method and system for optimizing minigenes and peptides encoded thereby |
ZA200206457B (en) | 2000-02-18 | 2003-08-13 | Yeda Res & Dev | Oral, nasal and pulmonary dosage formulations of copolymer 1. |
US20020077278A1 (en) | 2000-06-05 | 2002-06-20 | Yong V. Wee | Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
WO2002076503A1 (en) | 2000-06-20 | 2002-10-03 | Mayo Foundation For Medical Education And Research | Treatment of central nervous system diseases by antibodies against glatiramer acetate |
WO2003029276A2 (en) * | 2001-10-03 | 2003-04-10 | President And Fellows Of Harvard College | Copolymers for suppression of autoimmune diseases, and methods of use |
EP1459065B1 (en) | 2001-12-04 | 2010-07-28 | Teva Pharmaceutical Industries, Ltd. | Processes for the measurement of the potency of glatiramer acetate |
US7655221B2 (en) | 2004-05-07 | 2010-02-02 | Peptimmune, Inc. | Methods of treating disease with random copolymers |
CN111704651B (zh) * | 2020-07-27 | 2021-10-08 | 南京安吉生物科技有限公司 | 具有抗衰老作用的多肽rv3和rv4及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3514587A1 (de) * | 1985-04-23 | 1986-10-30 | Victor Dipl.-Chem. Dr.med. 6200 Wiesbaden Brantl | Pharmakologisch aktive peptide |
KR910700259A (ko) * | 1989-01-12 | 1991-03-14 | 리차드 이. 림바크 | T-세포 인지성 펩티드 변형에 의해 면역반응에 영향을 주는 방법 |
-
1991
- 1991-07-29 AU AU83054/91A patent/AU8305491A/en not_active Abandoned
- 1991-07-29 WO PCT/EP1991/001420 patent/WO1992002543A1/en active Application Filing
- 1991-07-30 IL IL99008A patent/IL99008A0/xx unknown
- 1991-07-30 PT PT98501A patent/PT98501A/pt not_active Application Discontinuation
- 1991-07-31 MX MX9100454A patent/MX9100454A/es unknown
- 1991-07-31 IE IE270191A patent/IE912701A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1992002543A1 (en) | 1992-02-20 |
PT98501A (pt) | 1992-05-29 |
IE912701A1 (en) | 1992-02-12 |
IL99008A0 (en) | 1992-07-15 |
AU8305491A (en) | 1992-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9100454A (es) | Nuevos peptidos inmunosupresores y metodo para su preparacion | |
MX24568A (es) | 3-arilcarbonil-1h-indoles y procedimiento para su preparacion. | |
MX174176B (es) | Compuestos azo y procedimiento para su preparacion | |
MX9100657A (es) | Metodo para separar y/o mezclar con gas rociado centrifugamente | |
MX9100031A (es) | Compuestos de amino silicona y procedimiento para su preparacion | |
MX9101237A (es) | Xantinas substituidas y procedimiento para su preparacion | |
MX9201355A (es) | Bis-naftal imidas y metodo para su preparacion. | |
MX26267A (es) | Aminobenzodiacepinas y procedimiento para su prepaacion. | |
MX16687A (es) | Compuestos de biarilo y procedimiento para su preparacion. | |
MX9204920A (es) | Cianofenilpirroles y procedimiento para su obtencion. | |
MX9201780A (es) | Eteres oximicos y procedimiento para su preparacion. | |
MX9101235A (es) | Xantinas substituidas y procedimiento para su preparacion | |
MX9100845A (es) | Nuevas tienodiazepinas y procedimiento para su preparacion | |
MX22255A (es) | Compuestos de piridinil-quinolona y procedimiento para su preparacion. | |
MX9100415A (es) | Piridinas substituidas y procedimiento para su obtencion | |
MX9100952A (es) | Composiciones de tereftalato de polietileno y metodos para su uso | |
MX9100743A (es) | Compuestos heterociclicos y procedimiento para su preparacion | |
MX21243A (es) | Indenoindoles y procedimiento para su preparacion. | |
MX164079B (es) | 3-aroiloxifenilcarbamatos polimerizables y metodos para su preparacion y uso | |
MX9205747A (es) | Pirazolinas y procedimiento para su preparacion. | |
MX9100811A (es) | Indolonaftiridinas y procedimiento para su preparacion | |
MX9205821A (es) | Pirimidinil- y triazinileteres y -tioeteres y procedimiento para su preparacion. | |
MX9205746A (es) | Pirazolinas y procedimiento para su preparacion. | |
MX9102583A (es) | Microgranallas para vidriado y procedimiento para su obtencion. | |
MX9202536A (es) | Antibioticos tetraciclicos y procedimiento para su preparacion. |